A case-control study of oxidized low density lipoproteins and preeclampsia risk

Gynecological Endocrinology

Volumn 21, Issue 4, 2005, Pages 193-199

  Sanchez, Sixto E ^a   Williams, Michelle A ^b   Muy Mvera, Martin ^b   Qiu, Chunfang ^b   Vadachkoria, Surab ^b   Bazul, Victor ^c  

^a HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^b SWEDISH MEDICAL CENTER   (United States)

^c Materno Perinatal Institute   (Peru)

Author keywords

Lipids; Oxidative stress; Oxidized low density lipoprotein; Preeclampsia; Pregnancy

Indexed keywords

CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MATERNAL PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; RISK ASSESSMENT; SOLID; STANDARD;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOPROTEINS, LDL; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TRIGLYCERIDES;

EID: 28844481894     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590500154019     Document Type: Article

References (26)

1. Williams MA, Mittendorf R. Maternal morbidity. In: Goldman MB, Hatch M, editors. Women & health. New York: Academic Press Inc.; 2000. pp 172-181.
2. Mittendorf R, Lain KY, Williams MA, Walker CK. Preeclampsia: A nested case-control study of risk factors and their interactions. J Reprod Med 1996;41:491-496.
3. Robertson WB, Khong TY, Brosens I, Wolf FD, Sheppard BL, Bonner J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986;155:401-412.
4. Roberts JM, Redman CW. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993;341:1447-1451.
5. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol 1998;16:93-104.
6. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in preeclamptic and normotensive Peruvian women. Intl J Gynecol Obstet 1999;67:147-155.
7. 12 and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 2001;153:474-480.
8. Vadachkoria S, Sanchez SE, Qiu CF, Muy-Rivera M, Malinow MR, Williams MA. Evaluation of a possible interaction between hyperhomocyst(e)inemia & elevated soluble vascular cell adhesion molecule-1 in predicting preeclampsia. Gynecol Obstet Invest 2004;58:133-139.
9. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:574-581.
10. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second-trimester serum tumor necrosis factor-α soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999;149:323-329.
11. Qiu C, Luthy DA, Zhang C, Sorensen TK, Leisenring WM, Frederick IO, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of preeclampsia. AmJ Hypertens 2004;17:154-160.
12. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Tech Bull 1996;219:1-8.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
14. Hsieh CC, Maisonneuve P, Boyle P, Macfarlane GJ, Robertson C. Analysis of quantitative data by quantiles in epidemiologic studies: Classification according to cases, noncases or all subjects. Epidemiology 1991;2:137-140.
15. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998.
16. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994;343:645-646.
17. Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper-oxidised and mondialdehyde-modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 1998;105:1113-1117.
18. Kurki T, Ailus K, Palosuo T, Ylikorkala O. Oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hyperten Preg 1996;15:251-256.
19. Bowen RS, Moodley J, Dutton MF, Fickl H. Antibodies to oxidised low-density lipoproteins and cardiolipin in preeclampsia and eclampsia. J Obstet Gynaecol 2002;22:123-126.
20. Jain M, Sawhney H, Aggarwal N, Vashistha K, Majumdhar S. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia. J Obstet Gynaecol Res 2004;30:188-192.
21. Fialova L, Mikulikova L, Malbohan I, Benesova O, Stipek S, Zima T, Zwinger A. Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res 2002;51:355-361.
22. Holvet P, Mertens A, Verhamne P, Bogaerts K, Beyens G, Verhaeghe R, Collem D, Muls F, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:844-848.
23. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998;98:1487-1494.
24. Fredrikson GN, Hedblad B, Berglund G, Nilsson J. Plasma oxidized LDL: A predictor for acute myocardial infaction. J Intern Med 2003;253:425-429.
25. Frostegard J, Wu R, Lemne C, Thulin T, Witztum JL, de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci 2003;105:615-620.
26. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmunity Rev 2002;1:233-237.